| UBS (LUX) DIGITAL HEALTH EQUITY (GBP HEDGED) QL-ACC | RVI SALUD | 10,25% | · | · | · |
| UBS (LUX) DIGITAL HEALTH EQUITY I-A1-ACC | RVI SALUD | 11,82% | 21,39% | -29,35% | · |
| UBS (LUX) DIGITAL HEALTH EQUITY I-A2-ACC | RVI SALUD | 11,86% | 21,76% | -28,86% | · |
| UBS (LUX) DIGITAL HEALTH EQUITY I-B-ACC | RVI SALUD | 12,71% | 24,66% | -26,01% | · |
| UBS (LUX) DIGITAL HEALTH EQUITY K-1-ACC | RVI SALUD | 11,59% | 20,89% | -29,69% | · |
| UBS (LUX) DIGITAL HEALTH EQUITY N-ACC | RVI SALUD | 11,30% | 15,37% | -34,75% | · |
| UBS (LUX) DIGITAL HEALTH EQUITY P-ACC | RVI SALUD | 10,81% | 18,37% | -32,11% | · |
| UBS (LUX) DIGITAL HEALTH EQUITY Q-ACC | RVI SALUD | 11,78% | 21,26% | -29,48% | · |
| UBS (LUX) DIGITAL HEALTH EQUITY QL-ACC | RVI SALUD | 11,97% | · | · | · |
| UBS (LUX) DIGITAL HEALTH EQUITY SEEDING P-ACC | RVI SALUD | 12,15% | 22,72% | -27,91% | · |
| UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) (CHF HEDGED) QL-DIST | DEUDA PÚBLICA EMERGENTES | -3,79% | · | · | · |
| UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) (EUR HEDGED) QL-ACC | DEUDA PÚBLICA EMERGENTES | 1,41% | · | · | · |
| UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) QL-ACC | DEUDA PÚBLICA EMERGENTES | 7,15% | · | · | · |
| UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) QL-DIST | DEUDA PÚBLICA EMERGENTES | 1,83% | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (CHF HEDGED) I-A1-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | -7,09% | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (CHF HEDGED) I-B-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | -6,63% | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (CHF HEDGED) K-1-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | -7,22% | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (CHF HEDGED) P-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | -7,69% | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (EUR HEDGED) I-A1-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | -3,79% | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (EUR HEDGED) I-B-DIST | DEUDA PRIVADA EMERGENTES HRD CCY | -4,58% | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (EUR HEDGED) K-1-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | -3,91% | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (EUR HEDGED) P-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | -4,41% | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (EUR HEDGED) Q-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | -4,03% | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND I-A1-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | 1,14% | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND I-A2-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | 1,24% | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND I-B-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | 1,64% | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND I-B-DIST | DEUDA PRIVADA EMERGENTES HRD CCY | 0,31% | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND K-1-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | 1,00% | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND K-1-DIST | DEUDA PRIVADA EMERGENTES HRD CCY | -0,17% | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND P-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | 0,50% | · | · | · |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND Q-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | 0,90% | · | · | · |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) QL-ACC | RVI BIOTECNOLOGÍA | 40,31% | 57,55% | 42,47% | · |
| UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR HEDGED) P-ACC | RVI CHINA | -19,34% | 7,52% | -32,65% | · |
| UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR HEDGED) Q-ACC | RVI CHINA | -18,42% | 10,98% | -29,16% | · |
| UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR) I-A1-ACC | RVI CHINA | -13,81% | 9,46% | -18,28% | · |
| UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR) P-ACC | RVI CHINA | -14,82% | 5,64% | -22,95% | · |
| UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR) Q-ACC | RVI CHINA | -13,84% | 9,07% | -18,95% | · |
| UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) I-A3-ACC | RVI CHINA | -13,73% | 10,38% | -17,61% | · |
| UBS (LUX) EQUITY FUND - GLOBAL SUSTAINABLE (USD) (CHF PORTFOLIO HEDGED) F-ACC | RVI GLOBAL | 10,57% | 51,18% | · | · |
| UBS (LUX) EQUITY FUND - GLOBAL SUSTAINABLE (USD) (EUR HEDGED) P-ACC | RVI GLOBAL | 10,75% | 51,65% | 36,21% | · |
| UBS (LUX) EQUITY FUND - GLOBAL SUSTAINABLE (USD) (EUR) P-ACC | RVI GLOBAL | 17,90% | · | · | · |
| UBS (LUX) EQUITY FUND - GLOBAL SUSTAINABLE (USD) (EUR PORTFOLIO HEDGED) F-ACC | RVI GLOBAL | 14,03% | 57,92% | · | · |
| UBS (LUX) EQUITY FUND - GLOBAL SUSTAINABLE (USD) (EUR) Q-ACC | RVI GLOBAL | 18,88% | 55,48% | 63,93% | · |
| UBS (LUX) EQUITY FUND - GLOBAL SUSTAINABLE (USD) (GBP PORTFOLIO HEDGED) F-ACC | RVI GLOBAL | 18,19% | 66,87% | · | · |
| UBS (LUX) EQUITY FUND - GLOBAL SUSTAINABLE (USD) (USD PORTFOLIO HEDGED) F-ACC | RVI GLOBAL | 20,68% | 57,11% | · | · |
| UBS (LUX) EQUITY FUND - SUSTAINABLE HEALTH TRANSFORMATION (USD) (CHF HEDGED) P-ACC | RVI SALUD | 9,40% | 20,62% | · | · |
| UBS (LUX) EQUITY FUND - SUSTAINABLE HEALTH TRANSFORMATION (USD) (CHF HEDGED) Q-ACC | RVI SALUD | 10,28% | 23,53% | · | · |
| UBS (LUX) EQUITY FUND - SUSTAINABLE HEALTH TRANSFORMATION (USD) (EUR HEDGED) P-ACC | RVI SALUD | 12,92% | 26,41% | · | · |
| UBS (LUX) EQUITY FUND - SUSTAINABLE HEALTH TRANSFORMATION (USD) (EUR HEDGED) Q-ACC | RVI SALUD | 13,83% | 29,46% | · | · |
| UBS (LUX) EQUITY FUND - SUSTAINABLE HEALTH TRANSFORMATION (USD) F-ACC | RVI SALUD | 20,84% | 30,43% | · | · |
